Precision and Reliability – 365 Days a Year

The itm Group is a leading pharmaceutical company for the development, production and worldwide distribution of highly effective radionuclides for diagnostics (soon to be GMP-certified) and therapy (GMP-certified since 12/2011). A team of experts is working passionately and enthusiastically towards further developing exclusive next-generation radionuclide concepts and advanced medical devices, particularly in the treatment of neuroendocrine tumors, skin cancer and endovascular therapy. Strengthening R&D efforts while further expanding the esteemed network of global sales and strategic cooperation partners, is our number one priority in order to remain the provider of choice in radionuclide technology.

Headquartered on the premises of the elite Technical University of Munich TUM and next door to the novel FRM II – one of the most modern neutron source in the world – this high-tech environment provides us with the ideal setup to drive forth radionuclide technologies. A state of the art GMP Labeling Platform and sophisticated radiopharmaceutical supply chain management contribute to our success. The itm AG and its subsidiaries itg GmbH, itm OncoBeta GmbH and RP München GmbH are renowned for their excellence and precision in R&D and production, as well as for their unprecedented reliability and flexibility in terms of offering global logistic services and customer care, 365 days a year.